ImmunologybioRxivPreprint
Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response
N. K. Routhu, S. Gangadhara, N. Cheedarla…·R. R. Amara
This study develops two MVA-based SARS-CoV-2 vaccines, MVA/S and MVA/S1, and finds that MVA/S induces stronger neutralizing antibodies against SARS-CoV-2 compared to MVA/S1.
DOI 10.1101/2020.06.27.175166